| Title : Gliptins - do they increase cardiovascular risk or benefit? - Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| Author(s) : Doggrell SA , Dimmitt SB |
| Ref : Expert Opin Drug Safety , 13 :675 , 2014 |
| Abstract : |
| PubMedSearch : Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| PubMedID: 24684173 |
| Title : Gliptins - do they increase cardiovascular risk or benefit? - Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| Author(s) : Doggrell SA , Dimmitt SB |
| Ref : Expert Opin Drug Safety , 13 :675 , 2014 |
| Abstract : |
| PubMedSearch : Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| PubMedID: 24684173 |
| Title : Gliptins - do they increase cardiovascular risk or benefit? - Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| Author(s) : Doggrell SA , Dimmitt SB |
| Ref : Expert Opin Drug Safety , 13 :675 , 2014 |
| Abstract : |
| PubMedSearch : Doggrell_2014_Expert.Opin.Drug.Saf_13_675 |
| PubMedID: 24684173 |
| Title : Treatment of dementia with neurotransmission modulation - Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| Author(s) : Doggrell SA , Evans S |
| Ref : Expert Opin Investig Drugs , 12 :1633 , 2003 |
| Abstract : |
| PubMedSearch : Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| PubMedID: 14519085 |
| Title : Treatment of dementia with neurotransmission modulation - Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| Author(s) : Doggrell SA , Evans S |
| Ref : Expert Opin Investig Drugs , 12 :1633 , 2003 |
| Abstract : |
| PubMedSearch : Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| PubMedID: 14519085 |
| Title : Treatment of dementia with neurotransmission modulation - Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| Author(s) : Doggrell SA , Evans S |
| Ref : Expert Opin Investig Drugs , 12 :1633 , 2003 |
| Abstract : |
| PubMedSearch : Doggrell_2003_Expert.Opin.Investig.Drugs_12_1633 |
| PubMedID: 14519085 |